Teva Pharmaceuticals @TevaUSA
At a recent FDA public meeting, Teva’s VP of Regulatory Affairs for Generics in North America, Scott Tomsky, called for a more flexible and innovative approach to generic drug review. #Generics https://t.co/zzllrpC40o https://t.co/iytAxPE3Rk — PolitiTweet.org